CN108929217A - A kind of preparation method of 2- methyl -5- fluobenzoic acid - Google Patents

A kind of preparation method of 2- methyl -5- fluobenzoic acid Download PDF

Info

Publication number
CN108929217A
CN108929217A CN201710384266.4A CN201710384266A CN108929217A CN 108929217 A CN108929217 A CN 108929217A CN 201710384266 A CN201710384266 A CN 201710384266A CN 108929217 A CN108929217 A CN 108929217A
Authority
CN
China
Prior art keywords
acid
methyl
preparation
fluobenzoic
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710384266.4A
Other languages
Chinese (zh)
Other versions
CN108929217B (en
Inventor
王学跃
李功勇
陈克喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Qixun Pharmaceutical Technology Co., Ltd.
Original Assignee
Shanghai New Port Pharmaceutical Technology Co Ltd
Zhejiang Tianyu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai New Port Pharmaceutical Technology Co Ltd, Zhejiang Tianyu Pharmaceutical Co Ltd filed Critical Shanghai New Port Pharmaceutical Technology Co Ltd
Priority to CN201710384266.4A priority Critical patent/CN108929217B/en
Publication of CN108929217A publication Critical patent/CN108929217A/en
Application granted granted Critical
Publication of CN108929217B publication Critical patent/CN108929217B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/15Preparation of carboxylic acids or their salts, halides or anhydrides by reaction of organic compounds with carbon dioxide, e.g. Kolbe-Schmitt synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/08Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups

Abstract

The invention discloses a kind of preparation methods of 2- methyl -5- fluobenzoic acid, and the method includes reacting 2-X-4- toluene fluoride with magnesium chips to generate Grignard Reagent, and the Grignard Reagent made converts to obtain 2- methyl -5- fluobenzoic acid;Wherein X selects chlorine, bromine or iodine.

Description

A kind of preparation method of 2- methyl -5- fluobenzoic acid
Technical field
The present invention relates to field of medicine and chemical technology more particularly to a kind of preparation methods of 2- methyl -5- fluobenzoic acid.
Background technique
Oophoroma is common one of the malignant tumour of female sex organ, and the death rate but accounts for the first place of all kinds of gynecological tumors, Women's life is caused to seriously threaten.Clovis Oncology company obtains in the treatment of ovarian cancer drug Rucaparib ground The breakthrough therapeutic agent qualification of FDA, this drug is by inhibiting Poly adenosine diphosphate-ribose polymerase-1 class (PARPs) to play Effect, it can hinder the generation for certain gene mutations that cancer can be made to spread in whole body.It is breakthrough that FDA authorizes Rucaparib Therapeutic agent label covers it and is used to treat the BRCA mutation Patients with Advanced Ovarian Carcinoma for previously receiving the failure of second line treatment drug.2- Methyl-3-nitro -5- fluorophenyl carbamate is the important intermediate of Rucaparib anticancer drug, usual 2- methyl -5- fluorobenzene first Acid can be used as the starting material for preparing it.
Therefore, there is an urgent need in the art to provide a kind of method for obtaining 2- methyl -5- fluobenzoic acid.
Summary of the invention
The present invention is intended to provide a kind of preparation method of 2- methyl -5- fluobenzoic acid, then obtains 2- methyl-3-nitro - 5- fluorophenyl carbamate.
In the first aspect of the present invention, a kind of preparation method of 2- methyl -5- fluobenzoic acid is provided, the method includes 2-X-4- toluene fluoride is reacted with magnesium chips and generates Grignard Reagent, and the Grignard Reagent made converts to obtain 2- methyl -5- fluorobenzene Formic acid;Wherein X selects chlorine, bromine or iodine;The conversion is mixed after the Grignard Reagent that will be obtained and carbon dioxide reaction with acid solution Conjunction obtains 2- methyl -5- fluobenzoic acid.
In another preferred example, with organic molten after the conversion is the Grignard Reagent that will be obtained and acid solution mixing, is layered Organic phase is obtained by extraction in agent 1, directly removes solvent and obtains 2- methyl -5- fluobenzoic acid.
In another preferred example, the conversion includes step:
(a) organic phase is obtained by extraction with organic solvent 1 after obtained Grignard Reagent and acid solution being mixed, be layered;
(b) organic phase, organic solvent 2 and aqueous slkali are mixed, layering, obtains water phase;With
(c) 2- methyl -5- fluobenzoic acid is obtained after mixing water phase and acid solution.
In another preferred example, the acid solution is the aqueous solution of inorganic acid, therein inorganic with the total volume meter of solution The content of acid is 10-15v/v%;The aqueous slkali is the aqueous solution of inorganic base, therein inorganic with the total volume meter of solution The content of alkali is 5-15v/v%;The inorganic acid is selected from hydrochloric acid, sulfuric acid, phosphoric acid;The inorganic base is selected from sodium hydroxide, hydrogen-oxygen Change potassium, sodium carbonate or potassium carbonate.
In another preferred example, organic solvent 1 is selected from ethyl acetate, isopropyl acetate or n-butyl acetate;It is described organic Solvent 2 is selected from toluene, methylene chloride, dimethylbenzene or methyl tertiary butyl ether(MTBE).
In another preferred example, step (a) and (c) in mixed with acid solution and make pH 1-2.
In another preferred example, the method includes the steps:
(i) 2-X-4- toluene fluoride is reacted with magnesium chips and generates Grignard Reagent;
(ii) by Grignard Reagent and carbon dioxide reaction, carboxylate is obtained;With
(iii) organic phase is obtained by extraction with organic solvent 1 after obtained carboxylate and acid solution being mixed, be layered, removes Solvent obtains 2- methyl -5- fluobenzoic acid;
Or including step:
(1) 2-X-4- toluene fluoride is reacted with magnesium chips and generates Grignard Reagent;
(2) by Grignard Reagent and carbon dioxide reaction, carboxylate is obtained;
(3) organic phase is obtained by extraction with organic solvent 1 after obtained carboxylate and acid solution being mixed, be layered;
(4) organic phase, organic solvent 2 and aqueous slkali are mixed, layering, obtains water phase;With
(5) 2- methyl -5- fluobenzoic acid is obtained after mixing water phase and acid solution.
In another preferred example, in step (i) or (1) magnesium chips in 1-3 times of mole;Reaction temperature in step (i) or (1) In 20 DEG C of -85 DEG C of reactions;Solvent for use is selected from following one or more in step (i) or (1):The tertiary ether of toluene, first, second Ether, isopropyl ether, tetrahydrofuran and methyltetrahydrofuran.
In another preferred example, step (ii) or the temperature of (2) are at -20 DEG C -50 DEG C;More preferably at 0-20 DEG C.
In another preferred example, the temperature of step (5) is at -10 DEG C -40 DEG C;More preferably at 0-10 DEG C.
In the second aspect of the present invention, a kind of preparation method of 2- methyl-3-nitro -5- fluorophenyl carbamate is provided, The method includes the steps:
(A) by the 2- methyl -5- fluobenzoic acid being prepared present invention as described above and dust technology, concentrated nitric acid or smoke Nitric acid reaction obtains 2- methyl-3-nitro -5- fluobenzoic acid;With
(B) 2- methyl-3-nitro -5- fluobenzoic acid is reacted to obtain 2- methyl-3-nitro -5- fluobenzoic acid first with methanol Ester.
In another preferred example, the reaction dissolvent of step (A) is selected from following one or more:Sulfuric acid, the concentrated sulfuric acid, Oleum, acetic acid and methylene chloride.
In another preferred example, the catalyst in step (B) is selected from following one or more:Sulfuric acid, chloroacetic chloride, Thionyl chloride and oxalyl chloride;Catalyst amount is 0.1-2 times of mole;In step (B) solvent for use be selected from following one kind or It is two or more:Toluene, methylene chloride and methanol;The reaction temperature of step (B) is at 0 DEG C -110 DEG C.
Accordingly, the present invention provides a kind of methods for obtaining 2- methyl -5- fluobenzoic acid.
Specific embodiment
After extensive and in-depth study, discovery can be reacted inventor under mild conditions by cheap raw material Obtain 2- methyl -5- fluobenzoic acid.On this basis, the present invention is completed.
Prepare 2- methyl -5- fluobenzoic acid
2- methyl -5- fluobenzoic acid preparation method provided by the invention includes the following steps:
The first step obtains Grignard Reagent by 2-X-4- toluene fluoride (X=Cl, Br, I) and magnesium chips;
Second step, by carboxyl in Grignard Reagent;
Third step, it is acidified to obtain 2- methyl -5- fluobenzoic acid.
In the above-mentioned first step, it will mix, do not surpassing in 2-X-4- toluene fluoride (X=Cl, Br, I) and the reaction dissolvent of magnesium chips It is reacted to obtain Grignard Reagent in the case where crossing 85 DEG C;The reaction dissolvent is toluene, the tertiary ether of first, ether, isopropyl ether, tetrahydro One of furans and methyltetrahydrofuran are several.
In the above-mentioned first step, reaction temperature is at 25-85 DEG C, preferably at 25-55 DEG C, more preferably at 25-35 DEG C.To solvent Dosage does not have particular/special requirement, as long as not influencing stable reaction progress.Preferred solvent dosage is 1-5 times of 2-X-4- toluene fluoride Volume.
The above-mentioned first step can be used conventional method (such as gas-chromatography) and carry out tracking and monitoring to the performance level of reaction.Instead Reaction temperature, solvent and specific reactant are depended between seasonable, under the above-described reaction conditions, generally 2-24h or so can be complete At reaction.
In one embodiment of the invention, above-mentioned second step is logical at -20 DEG C -50 DEG C after first step fully reacting Enter carbon dioxide gas until intermediate disappears substantially;It is preferred that at 0-20 DEG C;More preferably at 0-10 DEG C.
In one embodiment of the invention, after above-mentioned second step disappears substantially to intermediate, pH is made by acid solution For 1-2, layering, water phase organic solvent 1 merges organic phase after extracting, and organic phase, organic solvent 2 and aqueous slkali are mixed splitting or integrating Water phase is extracted with organic solvent 2 after layer, and resulting water phase makes pH 1-2 by acid solution again at -10 DEG C -40 DEG C after extraction, obtains To 2- methyl -5- fluobenzoic acid;It is preferred that at 0-10 DEG C.
The acid solution is the aqueous solution of inorganic acid, and with the total volume meter of solution, the content of inorganic acid therein is 10- 15v/v%;The inorganic acid is selected from hydrochloric acid, sulfuric acid or phosphoric acid.
The aqueous slkali is the aqueous solution of inorganic base, and with the total volume meter of solution, the content of inorganic base therein is 5- 15v/v%;The inorganic base is selected from sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate.
The organic solvent 1 is selected from ethyl acetate, isopropyl acetate or n-butyl acetate;The organic solvent 2 is selected from first Benzene, dimethylbenzene, methylene chloride or methyl tertiary butyl ether(MTBE).
In one embodiment of the invention, in above-mentioned third step, merge after being extracted by organic solvent 1 organic Crude product is obtained after being mutually concentrated, carries out subsequent operation after crude product, organic solvent 2 and aqueous slkali are mixed.
Prepare 2- methyl-3-nitro -5- fluorophenyl carbamate
2- methyl-3-nitro -5- fluorophenyl carbamate provided by the invention is the 2- that will be obtained by means of the present invention Methyl -5- fluobenzoic acid is nitrified to obtain 2- methyl-3-nitro -5- fluobenzoic acid, by 2- methyl-3-nitro -5- fluorobenzene first Acid is esterified to obtain 2- methyl-3-nitro -5- fluorophenyl carbamate.
The mode of nitrification is to use 2- methyl -5- fluobenzoic acid and nitric acid reaction, to obtain 2- methyl-3-nitro -5- fluorine Benzoic acid.Its nitric acid can use dust technology, concentrated nitric acid, fuming nitric aicd;It is preferred that fuming nitric aicd.Its dosage is equivalent to 2- methyl -3- nitre 1.2-2.5 times of mole of base -5- fluobenzoic acid.
Nitration reaction carries out in a solvent, and any solvent having no adverse effects to reaction, such as dilute sulfuric acid, dense sulphur can be used Acid, oleum, acetic acid, one of methylene chloride or several.The dosage of solvent does not have particular/special requirement, as long as not influencing anti- The stability answered, preferred solvent dosage are 4.0-8.0 times of volume of 2- methyl -5- fluobenzoic acid.
Reaction temperature does not have particular/special requirement, preferably 0 DEG C -50 DEG C, at preferred temperature, available good reaction effect Rate, nitration reaction yield can be to 60% or more.
Conventional method (such as thin-layer chromatography, liquid chromatogram etc.) can be used, tracking and monitoring is carried out to the performance level of reaction.Instead Reaction temperature, solvent and specific reactant are depended between seasonable, under the conditions of above-mentioned preferred, generally i.e. at 1-5 hours or so Achievable reaction.
The mode of esterification is 2- methyl-3-nitro -5- fluobenzoic acid and methanol reaction, to obtain 2- methyl -3- Nitro -5- fluorophenyl carbamate.Methanol usage is 1.5-30 times of mole of 2- methyl-3-nitro -5- fluobenzoic acid.
Reaction carries out in a solvent, can be used to any solvent for having no adverse effects of reaction, such as toluene, methylene chloride, One of methanol is several.The dosage of solvent does not have particular/special requirement, preferably molten as long as not influencing the stability of reaction Agent dosage is 2.0-8.0 times of volume of 2- methyl -3- nitro -5- fluobenzoic acid.
Reaction temperature does not have particular/special requirement, preferably 0 DEG C -110 DEG C, at preferred temperature, available good reaction Efficiency, esterification yield can be to 80% or more.
Conventional method (such as thin-layer chromatography, liquid chromatogram etc.) can be used, tracking and monitoring is carried out to the performance level of reaction.Instead Reaction temperature, solvent and specific reactant are depended between seasonable, under the conditions of above-mentioned preferred, generally i.e. at 2-8 hours or so Achievable reaction.
Target product 2- methyl-3-nitro -5- fluorophenyl carbamate can use fusing point test, and liquid phase is simple, and nuclear-magnetism is total The methods of vibration testing identity.
Next step reaction can directly be carried out after the reaction was completed by respectively walking involved in preparation method provided by the invention, but be adopted The intermediate product that each step is reacted is isolated and purified with post processing modes such as extraction, suction filtration, washing, drying, concentrations to be conducive to mention The efficiency of relative superiority or inferiority single step reaction.
The feature that the features described above or embodiment that the present invention mentions are mentioned can be in any combination.Disclosed in this case specification All features can be used in combination with any composition form, each feature disclosed in specification, any can provide it is identical, The alternative characteristics of impartial or similar purpose replace.Therefore except there is special instruction, revealed feature is only impartial or similar spy The general example of sign.
Main advantages of the present invention are:
1, the raw material that method provided by the invention uses is cheap, is easy to get.
2, method side reaction provided by the invention is few, and production capacity is big, and reaction condition is milder, at low cost, easily industrializes Production.
3, purity after the 2- methyl-3-nitro -5- fluorophenyl carbamate that preparation method provided by the invention obtains is purified It can reach 99% or more, total recovery can reach 40% or more.
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention Rather than it limits the scope of the invention.In the following examples, the experimental methods for specific conditions are not specified, usually according to conventional strip Part or according to the normal condition proposed by manufacturer.Unless otherwise stated, otherwise all percentage, ratio, ratio or number is pressed Poidometer.The unit in percent weight in volume in the present invention is well-known to those skilled in the art, such as is referred to 100 The weight of solute in the solution of milliliter.Unless otherwise defined, all professional and scientific terms as used herein and this field are ripe It is identical to practice meaning known to personnel.In addition, any method similar to or equal to what is recorded and material all can be applied to In the method for the present invention.The preferred methods and materials described herein are for illustrative purposes only.
Embodiment 1
2- methyl -5- fluobenzoic acid is prepared with the chloro- 4- toluene fluoride of 2-
By magnesium chips 20g (0.83mol), methyltetrahydrofuran 100ml is added into the four-hole bottle of 1L, under nitrogen protection, is added Enter the chloro- 4- toluene fluoride of 10g (0.07mol) 2-, stirring is warming up to reaction and causes, 55 DEG C, cause successfully, and highly exothermic, stops Stirring, after stablizing, stirring is warming up to reflux, and the chloro- 4- toluene fluoride 90g (0.62mol) of remaining 2- is dissolved in the methyl of 300ml In tetrahydrofuran, slowly instill in above-mentioned reaction solution, and at reflux by temperature.9h is dripped, and reacts 2h, gas phase inspection It surveys, fully reacting.It is cooled to 0-10 DEG C, is passed through clean carbon dioxide gas, until intermediate disappears substantially.It is added dropwise 12% Hydrochloric acid solution is up to pH 1-2.Layering, water phase use ethyl acetate 200ml to extract 1 time again, merge organic phase, and concentration is dry, obtains slightly Product.Toluene 200ml is added.10% sodium hydrate aqueous solution 320g, stirring to dissolved clarification, stratification, water phase toluene 200ml Extraction 1 time.Organic phase is discarded, water phase is at 0-10 DEG C, with 12% hydrochloric acid tune pH to 1-2.There is a large amount of white solid to be precipitated.It crosses Filter, filter cake are rinsed with water, are drained, 50 DEG C of filter cake drying.Obtain crude product 80.4g, HPLC 90%.Pure yield 67.9%.This is thick Product can directly react in next step.
1H-NMR CDCl32.50 (S, 3H), 7.26-7.34 (m, 2H), 7.51-7.54 (d, 1H), 13.09 (S, 1H). LC-MS(MH-):153.1
Embodiment 2
2- methyl -5- fluobenzoic acid is prepared with the bromo- 4- toluene fluoride of 2-
By magnesium chips 20g (0.83mol), tetrahydrofuran 100ml is added into the four-hole bottle of 1L, and under nitrogen protection, 6g is added The bromo- 4- toluene fluoride of (0.032mol) 2-, stirring is warming up to reaction and causes, 25 DEG C, causes successfully, and heat release extremely flows back, ice-water bath 25 DEG C are cooled to, the bromo- 4- toluene fluoride 124g (0.66mol) of remaining 2- is dissolved in the tetrahydrofuran of 300ml, is slowly instilled It states in reaction solution, and 25-35 DEG C.2h is dripped, and reacts 2h, vapor detection, fully reacting.It is cooled to 0-10 DEG C, is passed through clean Carbon dioxide gas, until intermediate disappears substantially.The hydrochloric acid solution of dropwise addition 12% is up to pH 1-2.Layering, water phase is again It is extracted 1 time with ethyl acetate 200ml, merges organic phase, concentration is dry, obtains crude product.Toluene 200ml is added.10% sodium hydroxide Aqueous solution 320g, stirring to dissolved clarification, stratification, water phase are extracted 1 time with toluene 200ml.Organic phase is discarded, water phase is in 0-10 DEG C, with 12% hydrochloric acid tune pH to 1-2.There is a large amount of white solid to be precipitated.Filtering, filter cake are rinsed with water, are drained, and 50 DEG C of filter cake Drying.Obtain crude product 85g, HPLC 95%.Pure yield 75.8%.This crude product can directly react in next step.
1H-NMR CDCl32.50 (S, 3H), 7.26-7.34 (m, 2H), 7.51-7.54 (d, 1H), 13.09 (S, 1H). LC-MS(MH-):153.1
Embodiment 3
2- methyl -5- fluobenzoic acid is prepared with the iodo- 4- toluene fluoride of 2-
By magnesium chips 20g (0.83mol), the tertiary ether 100ml of first is added into the four-hole bottle of 1L, and under nitrogen protection, 6g is added The iodo- 4- toluene fluoride of (0.025mol) 2-, be stirred at room temperature it is lower cause successfully, and heat release, to 50 DEG C or so, ice-water bath is cooled to 25 DEG C, The iodo- 4- toluene fluoride 157g (0.665mol) of remaining 2- is dissolved in the tertiary ether of first of 300ml, is slowly instilled in above-mentioned reaction solution, And 25-35 DEG C.2h is dripped, and reacts 2h, vapor detection, fully reacting.It is cooled to 0-10 DEG C, is passed through clean carbon dioxide gas Body, until intermediate disappears substantially.The hydrochloric acid solution of dropwise addition 12% is up to pH 1-2.Layering, water phase use ethyl acetate again 200ml is extracted 1 time, merges organic phase, and concentration is dry, obtains crude product.Toluene 200ml is added.10% sodium hydrate aqueous solution 320g, Stirring to dissolved clarification, stratification, water phase is extracted 1 time with toluene 200ml.Organic phase is discarded, water phase is at 0-10 DEG C, with 12% salt Acid adjusts pH to 1-2.There is a large amount of white solid to be precipitated.Filtering, filter cake are rinsed with water, are drained, 50 DEG C of filter cake drying.Obtain crude product 90g, HPLC 96%.Pure yield 81%.This crude product can directly react in next step.
1H-NMR CDCl32.50 (S, 3H), 7.26-7.34 (m, 2H), 7.51-7.54 (d, 1H), 13.09 (S, 1H). LC-MS(MH-):153.1
Embodiment 4
The preparation of 2- methyl-3-nitro -5- fluobenzoic acid
2- methyl -5- the fluobenzoic acid of 30g (0.195mol) is added into the concentrated sulfuric acid of 120ml, under stirring, is warming up to 30℃-40℃.It is added dropwise concentrated nitric acid 24.5g (0.39mol), 30-40 DEG C of temperature control.After dripping off, 2h is reacted, raw material disappears substantially, stops It only reacts, reaction solution pours into ice water.Filtering, filter cake are rinsed with water, are drained.Wet product is obtained, 50 DEG C, drying obtains 28g, HPLC 95%.Pure yield 66.5%.
1H-NMR DMSO 2.45 (S, 3H), 7.83-7.85 (d, 1H), 8.02-8.04 (d, 1H), 13.78 (S, 1H). LC-MS(MH-):198.1
Embodiment 5
The preparation of 2- methyl-3-nitro -5- fluobenzoic acid
2- methyl -5- the fluobenzoic acid of 30g (0.195mol) is added into the acetic acid of 150ml, under stirring, is warming up to 40 ℃-50℃.It is added dropwise fuming nitric aicd 24.5g (0.39mol), 40-50 DEG C of temperature control.After dripping off, 3h is reacted, raw material disappears substantially, stops It only reacts, reaction solution pours into ice water.Filtering, filter cake are rinsed with water, are drained.Wet product is obtained, 50 DEG C, drying obtains 35g, HPLC 96%.Pure yield 84.
1H-NMR DMSO 2.45 (S, 3H), 7.83-7.85 (d, 1H), 8.02-8.04 (d, 1H), 13.78 (S, 1H). LC-MS(MH-):198.1
Embodiment 6
The preparation of 2- methyl-3-nitro -5- fluobenzoic acid
The methylene chloride to the concentrated sulfuric acid of 30ml and 150ml is added in the 2- methyl -5- fluobenzoic acid of 30g (0.195mol) Mixed liquor in, under stirring, be warming up to 30 DEG C -40 DEG C.It is added dropwise fuming nitric aicd 24.5g (0.39mol), 30-40 DEG C of temperature control.It drips off Afterwards, 3h is reacted, raw material disappears substantially, stops reaction, reaction solution pours into ice water.Filtering, filter cake are rinsed with water, are drained.? To wet product, 50 DEG C, drying obtains 30g, HPLC 94%.Pure yield 70.5%.
1H-NMR DMSO 2.45 (S, 3H), 7.83-7.85 (d, 1H), 8.02-8.04 (d, 1H), 13.78 (S, 1H). LC-MS(MH-):198.1
Embodiment 7
The preparation of 2- methyl-3-nitro -5- fluorophenyl carbamate
3g (15.1mmol) 2- methyl-3-nitro -5- fluobenzoic acid is added into the methanol of 30ml, under stirring, is added dropwise The 0.3g concentrated sulfuric acid (98%) is then refluxed for 8h, stops reaction, and sodium bicarbonate aqueous solution tune pH to 7 or so is added.Methanol is concentrated, After complete, methylene chloride 30ml is added, washes 2 times, saturated common salt is washed 1 time, and organic phase concentration is dry to obtain crude product, recrystallizing methanol 2 * 10ml obtain product 2.4g, 99% or more HPLC.Yield 74.8%.
1H-NMR DMSO 2.43 (S, 3H), 3.88 (S, 3H), 7.85-7.87 (d, 1H), 8.07-8.09 (d, 1H).LC- MS(MH+):214.1
Embodiment 8
The preparation of 2- methyl-3-nitro -5- fluorophenyl carbamate
58g (0.291mol) 2- methyl-3-nitro -5- fluobenzoic acid is added into 300ml methanol, is stirred, 0-10 DEG C, It is added dropwise thionyl chloride 41.6g (0.35mol), has obvious heat release, temperature control is at 20 DEG C or less.After dripping off, it is warming up to reflux, is reacted 7h, raw material disappear substantially, stop reaction, 25 DEG C are cooled under stirring, have a large amount of solids to be precipitated, filtering, filter cake 60ml methanol Rinsing, is drained, filter cake uses 150ml recrystallizing methanol again, obtains wet product, after drying, obtains 45g product.99% or more HPLC. Yield 72.6%.
1H-NMR DMSO 2.43 (S, 3H), 3.88 (S, 3H), 7.85-7.87 (d, 1H), 8.07-8.09 (d, 1H).LC- MS(MH+):214.1
Embodiment 9
The preparation of 2- methyl-3-nitro -5- fluorophenyl carbamate
By 30g (0.151mol) 2- methyl-3-nitro -5- fluobenzoic acid, 150ml toluene is added in 10g (0.31mol) methanol In solution, stirring is warming up to reflux, after reflux, is added dropwise thionyl chloride 18g (0.227mol), there is HCl gas releasing, after dripping off, Back flow reaction 2h, raw material disappear substantially, and reaction solution has muddy become to clarify.Stop reaction, concentrated solvent obtains crude product, uses methanol 2 * 100ml are recrystallized, product 28g, 99% or more HPLC, yield 87.2% are obtained.
1H-NMR DMSO 2.43 (S, 3H), 3.88 (S, 3H), 7.85-7.87 (d, 1H), 8.07-8.09 (d, 1H).LC- MS(MH+):214.1
The foregoing is merely illustrative of the preferred embodiments of the present invention, the substantial technological content model being not intended to limit the invention It encloses, substantial technological content of the invention is broadly defined in the scope of the claims of application, any technology that other people complete Entity or method also or a kind of equivalent change, will if identical with defined in the scope of the claims of application It is considered as being covered by among the scope of the claims.

Claims (14)

1. a kind of preparation method of 2- methyl -5- fluobenzoic acid, which is characterized in that the method includes by 2-X-4- toluene fluoride with Magnesium chips reaction generates Grignard Reagent, and the Grignard Reagent made converts to obtain 2- methyl -5- fluobenzoic acid;Wherein X select chlorine, Bromine or iodine.
2. preparation method as described in claim 1, which is characterized in that the conversion is the Grignard Reagent and titanium dioxide that will be obtained 2- methyl -5- fluobenzoic acid is mixed to get with acid solution after carbon reaction.
3. preparation method as described in claim 1, which is characterized in that the conversion is the Grignard Reagent that will be obtained and acid solution Organic phase is obtained by extraction with organic solvent 1 after mixing, layering, directly removes solvent and obtains 2- methyl -5- fluobenzoic acid;Or packet Include step:
(a) organic phase is obtained by extraction with organic solvent 1 after obtained Grignard Reagent and acid solution being mixed, be layered;
(b) organic phase, organic solvent 2 and aqueous slkali are mixed, layering, obtains water phase;
(c) 2- methyl -5- fluobenzoic acid is obtained after mixing water phase and acid solution.
4. preparation method as claimed in claim 3, which is characterized in that the acid solution is the aqueous solution of inorganic acid, with solution Total volume meter, the content of inorganic acid therein is 10-15v/v%;The aqueous slkali is the aqueous solution of inorganic base, with solution Total volume meter, the content of inorganic base therein is 5-15v/v%.
5. preparation method as claimed in claim 4, which is characterized in that the inorganic acid is selected from hydrochloric acid, sulfuric acid, phosphoric acid;It is described Inorganic base is selected from sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate.
6. preparation method as claimed in claim 3, which is characterized in that organic solvent 1 be selected from ethyl acetate, isopropyl acetate or N-butyl acetate,;The organic solvent 2 is selected from toluene, methylene chloride, dimethylbenzene or methyl tertiary butyl ether(MTBE).
7. preparation method as claimed in claim 3, which is characterized in that step (a) and (c) in mixed with acid solution and make pH 1- 2。
8. such as the described in any item preparation methods of claim 1-7, which is characterized in that the method includes the steps:
(i) 2-X-4- toluene fluoride is reacted with magnesium chips and generates Grignard Reagent;
(ii) by Grignard Reagent and carbon dioxide reaction, carboxylate is obtained;
(iii) organic phase is obtained by extraction with organic solvent 1 after obtained carboxylate and acid solution being mixed, be layered, removes solvent Obtain 2- methyl -5- fluobenzoic acid;Or
(1) 2-X-4- toluene fluoride is reacted with magnesium chips and generates Grignard Reagent;
(2) by Grignard Reagent and carbon dioxide reaction, carboxylate is obtained;
(3) organic phase is obtained by extraction with organic solvent 1 after obtained carboxylate and acid solution being mixed, be layered;
(4) organic phase, organic solvent 2 and aqueous slkali are mixed, layering, obtains water phase;
(5) 2- methyl -5- fluobenzoic acid is obtained after mixing water phase and acid solution.
9. preparation method as claimed in claim 8, which is characterized in that magnesium chips is in 1-3 times of mole in step (i) or (1);Step Suddenly reaction temperature is reacted at 20 DEG C -85 DEG C in (i) or (1);Solvent for use is selected from following one kind or two in step (i) or (1) Kind or more:The tertiary ether of toluene, first, ether, isopropyl ether, tetrahydrofuran and methyltetrahydrofuran.
10. preparation method as claimed in claim 8, which is characterized in that step (ii) or the temperature of (2) are at -20 DEG C -50 DEG C; It is preferred that at 0-20 DEG C.
11. preparation method as claimed in claim 8, which is characterized in that the temperature of step (5) is at -10 DEG C -40 DEG C;It is preferred that 0-10℃。
12. a kind of preparation method of 2- methyl-3-nitro -5- fluorophenyl carbamate, which is characterized in that the method includes steps Suddenly:
(A) such as claim 1-11 2- methyl -5- fluobenzoic acid being prepared and dust technology, concentrated nitric acid or fuming nitric aicd is anti- It should obtain 2- methyl-3-nitro -5- fluobenzoic acid;
(B) 2- methyl-3-nitro -5- fluobenzoic acid is reacted to obtain 2- methyl-3-nitro -5- fluorophenyl carbamate with methanol.
13. method as claimed in claim 12, which is characterized in that the reaction dissolvent of step (A) is selected from following one kind or two Kind or more:Sulfuric acid, the concentrated sulfuric acid, oleum, acetic acid and methylene chloride.
14. method as claimed in claim 12, which is characterized in that the catalyst in step (B) is selected from following one kind or two Kind or more:Sulfuric acid, chloroacetic chloride, thionyl chloride and oxalyl chloride;Catalyst amount is 0.1-2 times of mole;It is used molten in step (B) Agent is selected from following one or more:Toluene, methylene chloride and methanol;The reaction temperature of step (B) is at 0 DEG C -110 DEG C.
CN201710384266.4A 2017-05-26 2017-05-26 Preparation method of 2-methyl-5-fluorobenzoic acid Active CN108929217B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710384266.4A CN108929217B (en) 2017-05-26 2017-05-26 Preparation method of 2-methyl-5-fluorobenzoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710384266.4A CN108929217B (en) 2017-05-26 2017-05-26 Preparation method of 2-methyl-5-fluorobenzoic acid

Publications (2)

Publication Number Publication Date
CN108929217A true CN108929217A (en) 2018-12-04
CN108929217B CN108929217B (en) 2021-02-26

Family

ID=64451143

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710384266.4A Active CN108929217B (en) 2017-05-26 2017-05-26 Preparation method of 2-methyl-5-fluorobenzoic acid

Country Status (1)

Country Link
CN (1) CN108929217B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114790139A (en) * 2021-01-26 2022-07-26 江苏中旗科技股份有限公司 Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-amino bromobenzene as raw material

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232018A (en) * 1998-03-09 1999-10-20 罗姆和哈斯公司 Process for synthesizing benzoic acids
CN1358708A (en) * 2001-12-13 2002-07-17 中国科学院上海有机化学研究所 Method for synthesizing 2,3,4-trifluoro phenyl formic acid
US20050054733A1 (en) * 2003-09-09 2005-03-10 Petra Hilgers Difluoroalkylaromatics
CN101381301A (en) * 2007-09-06 2009-03-11 华东理工大学 Preparation method of 4-chloro-2,5-difluorobenzoic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232018A (en) * 1998-03-09 1999-10-20 罗姆和哈斯公司 Process for synthesizing benzoic acids
CN1358708A (en) * 2001-12-13 2002-07-17 中国科学院上海有机化学研究所 Method for synthesizing 2,3,4-trifluoro phenyl formic acid
US20050054733A1 (en) * 2003-09-09 2005-03-10 Petra Hilgers Difluoroalkylaromatics
CN101381301A (en) * 2007-09-06 2009-03-11 华东理工大学 Preparation method of 4-chloro-2,5-difluorobenzoic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114790139A (en) * 2021-01-26 2022-07-26 江苏中旗科技股份有限公司 Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-amino bromobenzene as raw material

Also Published As

Publication number Publication date
CN108929217B (en) 2021-02-26

Similar Documents

Publication Publication Date Title
CN102766138B (en) A kind of preparation method of Azilsartan
CN103910672B (en) The preparation method of Vismodegib
CN103570696B (en) A kind of preparation method of Axitinib intermediate and preparing the application in Axitinib
CN111303020B (en) Synthetic method of 5-chloro-2- (pyridine-3-yl) pyridine-3-amine
CN102675285A (en) Method for pure water phase preparation of rabeprazole sodium
CN115368272A (en) Preparation method of 4-cyano-2-methoxybenzaldehyde
CN105732444A (en) Synthesis method of belinostat
CN102351790B (en) Method for synthesizing 7-bromo-6-chloro-4-quinazolinone
CN105837493A (en) A synthetic method of Nintedanib and an intermediate of Nintedanib
CN108929217A (en) A kind of preparation method of 2- methyl -5- fluobenzoic acid
CN104829588B (en) A kind of Preparation Method And Their Intermediate of benzo [b] thiophene
CN104781231B (en) The method for preparing travoprost
CN105585511B (en) (R) preparation method of N tertbutyloxycarbonyls biphenyl Propanolamine
CN101260069A (en) Method for preparing nimesulide intermediate 2-phenoxymethanesulphonylaniline
CN104672180B (en) Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate
CN105924390A (en) Synthesis method of metafenib
CN106565522A (en) Method for preparing alkyloxy aromatic compound from fluoroaromatic compound
CN108884048B (en) Preparation method and intermediate of pyridone derivative
CN113121354A (en) Synthesis method of substituted biphenyl compound
CN106748884B (en) Preparation method of bicalutamide intermediate
CN106083693A (en) The N phthalyl synthesis technique to (dihydroxy ethyl) amino L phenylalanine ethyl ester
CN101985451A (en) Preparation method of prasugrel intermediate
CN107629039B (en) The preparation method and intermediate of deuterated acrylamide
CN106866493B (en) A kind of preparation method of Apremilast
WO2020147803A1 (en) SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-α]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20190510

Address after: 318020 Huangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province

Applicant after: Zhejiang Tianyu Pharmaceutical Co., Ltd.

Applicant after: Shanghai Qixun Pharmaceutical Technology Co., Ltd.

Address before: 318020 Huangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province

Applicant before: Zhejiang Tianyu Pharmaceutical Co., Ltd.

Applicant before: Shanghai new port Pharmaceutical Technology Co., Ltd.

GR01 Patent grant
GR01 Patent grant